stage IV nasopharyngeal cancer
Showing 1 - 25 of >10,000
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial
Not yet recruiting
- Metastatic Nasopharyngeal Carcinoma
- +2 more
- Nivolumab
- +5 more
- (no location specified)
Aug 21, 2023
Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- 5-fu
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023
Blood Tests and Questionnaires in Studying Adherence to
Recruiting
- Carcinoma of Unknown Primary
- +30 more
- Biospecimen Collection
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial
Not yet recruiting
- Metastatic Nasopharyngeal Carcinoma
- +2 more
- Biospecimen Collection
- +5 more
- (no location specified)
Jun 13, 2023
Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal
Not yet recruiting
- Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
- +15 more
- Best Practice
- +9 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Aug 23, 2022
Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8
Not yet recruiting
- Stage II Nasopharyngeal Carcinoma AJCC v8
- +2 more
- Biopsy
- +16 more
- (no location specified)
Oct 7, 2023
Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2022
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma
Not yet recruiting
- Stage IVA Nasopharyngeal Carcinoma
- Intensity modulated radiation therapy (IMRT) combined with chemotherapy
-
Nanjing, ChinaJiangsu Cancer Hospital
Jun 21, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +21 more
- Atezolizumab
- +8 more
-
Little Rock, Arkansas
- +97 more
Jan 27, 2023
Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- without concurrent cisplatin chemotherapy
- with concurrent cisplatin chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 18, 2023
Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)
Recruiting
- Nasopharyngeal Carcinoma
- mobile platform or not mobile platform
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023
Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Trial (Durvalumab,
Withdrawn
- Epstein-Barr Virus Positive
- +6 more
- Durvalumab
- Epacadostat
- (no location specified)
Oct 22, 2020
Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +10 more
- Discussion
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +11 more
- Acupressure Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 12, 2023
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Nasopharyngeal Carcinoma Trial in Beijing (Tislelizumab)
Recruiting
- Nasopharyngeal Carcinoma
-
Beijing, Beijing, ChinaNational Cancer Center /National Clinical Research Center for Ca
Jul 4, 2022
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Epacadostat
- +2 more
-
Minneapolis, Minnesota
- +1 more
Jan 27, 2023
Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)
Not yet recruiting
- Colorectal Cancer
- FOLFOX , FOLFIRI or FOLFOXIRI regimens
- FOLFOX regimen
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 26, 2023
Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (Toripalimab injection(subcutaneous)/JS001sc, Toripalimab /JS001)
Recruiting
- Advanced Nasopharyngeal Carcinoma
- Toripalimab injection(subcutaneous)/JS001sc
- Toripalimab /JS001
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 21, 2023
Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8 Trial in San
Completed
- Stage I Colorectal Cancer AJCC v8
- +12 more
- Dietary Intervention
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
Jan 5, 2023